The curious case of Yasmin(®): when does a generic's label induce doctors to practice a patented method of use?
Arnall Golden Gregory LLP, 171 17th Street NW, Atlanta, GA 30305, USA. clark.sullivan@agg.com.
Clark G
CG
Sullivan
D000736:Androstenes / Q000008:administration & dosage*; D000818:Animals; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000008:administration & dosage*; D004997:Ethinyl Estradiol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D010820:Physicians; D010818:Practice Patterns, Physicians'; D012102:Reproductive Control Agents / Q000008:administration & dosage*
D000736:Androstenes; D016568:Drugs, Generic; D012102:Reproductive Control Agents; C534342:drospirenone and ethinyl estradiol combination; D004997:Ethinyl Estradiol